UPDATE 1-AbbVie's profit beats on robust Humira demand
July 28, 2017 at 08:12 AM EDT
July 28 (Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira.
